Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
As with any medical treatment or supplement, the safety of peptides largely depends on the source, proper usage, and dosing
WernerTWagnerSJMartnezIWalterJChangJ-SClavelTet al
La semaglutida oral (Rybelsus) no se ha asociado a un aumento de la incidencia de retinopata diabtica
Zebrafish fed the HF diet exhibited a significant impairment in their ability to recognize and prefer the red-colored arm, which had been previously conditioned with a food reward
A couple of notes on this chart